Literature DB >> 8621803

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

K Uyemura1, L L Demer, S C Castle, D Jullien, J A Berliner, M K Gately, R R Warrier, N Pham, A M Fogelman, R L Modlin.   

Abstract

T cell cytokines are known to play a major role in determining protection and pathology in infectious disease. It has recently become clear that IL-12 is a key inducer of the type 1 T cell cytokine pattern characterized by production of IFN-gamma. Conversely, IL-10 down-regulates IL-12 production and type 1 cytokine responses. We have investigated whether IL-12 and IL-10 might be involved in a chronic inflammatory reaction, atherosclerosis. In atherosclerotic plaques, we found strong expression of IFN-gamma but not IL-4 mRNAs as compared to normal arteries. IL-12 p40 mRNA and IL-12 p70 protein were also found to be abundant in atherosclerotic plaques. IL-12 was induced in monocytes in vitro in response to highly oxidized LDL but not minimally modified LDL. The cross-regulatory role of IL-10 was indicated by the expression of IL-10 in some atherosclerotic lesions, and the demonstration that exogenous rIL-10 inhibited LDL-induced IL-12 release. These data suggest that the balance between IL-12 and IL-10 production contributes to the level of immune-mediated tissue injury in atherosclerotsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621803      PMCID: PMC507288          DOI: 10.1172/JCI118650

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis.

Authors:  A L Ramshaw; D V Parums
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

Review 2.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Authors:  A M Henney; P R Wakeley; M J Davies; K Foster; R Hembry; G Murphy; S Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

Review 4.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

Authors:  P Libby; G K Hansson
Journal:  Lab Invest       Date:  1991-01       Impact factor: 5.662

5.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor).

Authors:  M K Gately; B B Desai; A G Wolitzky; P M Quinn; C M Dwyer; F J Podlaski; P C Familletti; F Sinigaglia; R Chizonnite; U Gubler
Journal:  J Immunol       Date:  1991-08-01       Impact factor: 5.422

7.  Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure.

Authors:  P F Barnes; D Chatterjee; J S Abrams; S Lu; E Wang; M Yamamura; P J Brennan; R L Modlin
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

8.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.

Authors:  S Stemme; J Holm; G K Hansson
Journal:  Arterioscler Thromb       Date:  1992-02

9.  Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition.

Authors:  H F Hoff; T E Whitaker; J O'Neil
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  86 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

Review 3.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

4.  Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro.

Authors:  S Caspar-Bauguil; M Saadawi; A Negre-Salvayre; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  TNF-alpha and shear stress-induced large artery adaptations.

Authors:  C Keith Ozaki; Zhihua Jiang; Scott A Berceli
Journal:  J Surg Res       Date:  2007-06-15       Impact factor: 2.192

7.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 8.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

9.  The changing microbial environment and chronic inflammatory disorders.

Authors:  Graham Aw Rook
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

10.  Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients.

Authors:  C John Sperati; Rulan S Parekh; Yvette Berthier-Schaad; Bernard G Jaar; Laura Plantinga; Nancy Fink; Neil R Powe; Michael W Smith; Josef Coresh; W H Linda Kao
Journal:  Am J Kidney Dis       Date:  2009-03-12       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.